Ads
related to: multiple myeloma- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Contact a Representative
For Questions and Information
About This Treatment
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Primary and Subgroup Data
Search results
Metastatic multiple myeloma: Symptoms, treatment, and more
Medical News Today· 3 days agoMetastatic multiple myeloma is a form of cancer of the bone marrow that has spread to other parts of...
Multiple myeloma: Prognosis by age
Medical News Today· 3 days agoStatistics regarding multiple myeloma (MM) show that the survival rates are lower for older adults. This may stem from a combination of biological...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 2 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Quadruple Therapies and the Future of Multiple Mye | Newswise
Newswise· 4 days agoMIAMI, FLORIDA – The treatment landscape for multiple myeloma, the second most common blood cancer,...
Recent FDA committee vote could speed multiple myeloma drug approval
Medical Xpress· 4 days agoThis Landgren-led study, published May 20 in the journal Blood, featured a meta-analysis of a dozen...
Mississippi author Greg Iles to host rare reading, book launch Tuesday in Jackson
The Meridian Star· 14 hours agoBeneath the heading “medical announcement,” Iles wrote a letter to his readers to let them know that...
UH offers outpatient bone marrow transplants
News Channel 5 Cleveland· 4 days agoUniversity Hospitals is offering outpatient bone marrow transplants for Multiple Myeloma patients. Multiple Myeloma
Exposed to Agent Orange at US bases, vets face cancer without VA help
Military Times via Yahoo News· 10 hours agoAkey, who also worked with Elder, runs a Facebook group and keeps a list of people stationed on the...
MRD endpoint expected to usher new era for MM therapies
Clinical Trials Arena via Yahoo Finance· 5 days agoGiven the ODAC’s unanimous stance, the US regulatory agency is expected to use the surrogate...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 3 days agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing...
Ad
related to: multiple myeloma
